| HC (n = 70) | MDD (n = 70) | p value |
---|---|---|---|
Age (years) | 28.2 (SD 7.3) | 28.3 (SD 7.2) | .926 |
Sex | Â | Â | 1.000 |
 Male | 16 (22.9%) | 16 (22.9%) |  |
 Female | 54 (77.1%) | 54 (77.1%) |  |
Ethnicity | Â | Â | 1.000 |
 Chinese | 45 (64.3%) | 45 (64.3%) |  |
 Malay | 15 (21.4%) | 15 (21.4%) |  |
 Indian | 9 (12.9%) | 9 (12.9%) |  |
 Eurasian | 1 (1.4%) | 1 (1.4%) |  |
Education (years) | 15.6 (SD 1.2) | 14.5 (SD 1.8) | < .001 |
HAM-D | 1.9 (SD 2.5) | 19.8 (SD 5.4) | < .001 |
 Mild (8 – 16) | 4 (5.7%) | 20 (28.6%) |  |
 Moderate (17 – 23) | 0 | 30 (42.9%) |  |
 Severe (≥ 24) | 0 | 19 (27.1%) |  |
Family psychiatric history | 17 (24.3%) | 30 (42.9%) | .032 |
Age at onset (years) | Â | 20.7 (SD 7.5) | Â |
Duration of illness (years) | Â | 7.9 (SD 6.5) | Â |
Past admission to psychiatric ward | Â | 16 (22.9%) | Â |
Past suicide attempt | Â | 32 (45.7%) | Â |
Pharmacotherapy | Â | 60 (85.7%) | Â |
 Antidepressants |  | 60 (100%) |  |
 Anxiolytics and sedatives |  | 11 (18.3%) |  |
 Antipsychotics |  | 11 (18.3%) |  |
 Mood stabiliser |  | 4 (6.7%) |  |
 Fluoxetine equivalent dose (mg/day) |  | 72.6 (SD 71.8) |  |
 Diazepam equivalent dose (mg/day) |  | 38.6 (SD 74.3) |  |
 Chlorpromazine equivalent dose (mg/day) |  | 40.1 (SD 29.9) |  |